Skip to Main Content

Cancer startups aren’t exactly underfunded — as a disease area, oncology has commanded investors’ attention for the last decade.

But the American Cancer Society sees gaps.


“Oncology actually is very well-resourced and invested in. The challenge is, is the money going to the areas where there’s the greatest impact?” said Alice Pomponio, the managing director of the society’s venture capital arm, BrightEdge.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Create a display name to comment

This name will appear with your comment

There was an error saving your display name. Please check and try again.